| DUR | drug use review; drug utilization review |
|---|---|
| PRC | packed red cells; peer review committee; phase response curve; plasma renin concentration; professio... |
| ECOG | Eastern Cooperative Oncology Group |
| HFRS | Hemorrhagic Fever with Renal Syndrome [HP 849-50] = Korean Hemorrhagic Fever &nbs... |
| ECOG | Eastern Cooperative Oncology Group |
| review | 1. A second or repeated view; a reexamination; a retrospective survey; a looking over again; as, a review of one's studies; a review of life. 2. An examination with a view to amendment or improvement; revision; as, an author's review of his works. 3. A critical examination of a publication, with remarks; a criticism; a critique. 4. A periodical containing critical essays upon matters of interest, as new productions in literature, art, etc. 5. An inspection, as of troops under arms or of a naval force, by a high officer, for the purpose of ascertaining the state of discipline, equipments, etc. 6. The judicial examination of the proceedings of a lower court by a higher. 7. A lesson studied or recited for a second time. Bill of review, a commission formerly granted by the crown to revise the sentence of the court of delegates. Synonym: Reexamination, resurvey, retrospect, survey, reconsideration, revisal, revise, revision. Origin: F. Revue, fr. Revu, p. P. Of revoir to see again, L. Revidere; pref. Re- re- + videre to see. See View, and cf. Revise. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| review, academic | A more or less comprehensive review of the literature on a specific subject, with usually an extensive critical analysis and synthesis of the literature. (12 Dec 1998) |
| review literature | Published material which provides an examination of recent or current literature. Reviews can cover a wide range of subject matter of various levels of completeness or comprehensiveness based on analyses of publications on the subject. The review may reflect the state of the art. It also includes reviews as a literary form. The presence of research findings or case reports does not preclude designation as a review. (12 Dec 1998) |
| review, multicase | A type of review literature giving demographic, laboratory, and clinical data on a group of persons or animals ranging from most of the known cases of a rare condition in large populations on whom the results of research will lead to the establishing of epidemiological analyses or predictions of the occurrence and natural history of diseases. It is differentiated from review of reported cases in that the latter generally reports a single case as a supplement to a presentation, however brief and limited, of other cases known to have been reported. (12 Dec 1998) |
| review of reported cases | Literature reporting - to the best of the author's ability - all known cases of a disease. The study is usually generated by the investigator's encounter with patients with a given disease and includes the investigator's own cases. The range of time will encompass historical cases and recent cases. The review usually cites the literature in which the known cases were published and may or may not include clinical and laboratory data. (12 Dec 1998) |
| review, tutorial | A type of review citing literature that will give the user a general and reasonably thorough coverage of a subject with which he may or may not be familiar. It often substitutes as a refresher course for a physician to update his or her awareness or as a crash course for a student unfamiliar with the subject. (12 Dec 1998) |
| physician payment review commission | A commission created by the consolidated omnibus reconciliation act of 1985, enacted in 1986, and given the mandate to advise congress on medicare-physician payment. The commission members are appointed by the u.s. Office of technology assessment. (12 Dec 1998) |
| concurrent review | Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment. (12 Dec 1998) |
| professional review organizations | Organizations representing designated geographic areas which have contracts under the pro program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by medicare beneficiaries. Peer review improvement act, pl 97-248, 1982. (12 Dec 1998) |
| scientific integrity review | Designation for reports by the united states office of research integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the nih guide for grants and contracts. (12 Dec 1998) |
| drug utilization review | Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993. (12 Dec 1998) |
| insurance claim review | Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality. (12 Dec 1998) |
| utilization review | An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use. (12 Dec 1998) |
| academic medical centres | Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. (12 Dec 1998) |
| advance medical directives | Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society). (12 Mar 2000) |